Anthem Biosciences Limited

Quant Mutual Fund trimmed its stake in Anthem Biosciences from 1.64% to 1.47%, selling 933,851 shares for ₹72.56 Cr at ₹777.00 apiece.

A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.

Built a quantitative, data-driven investment philosophy in an industry dominated by discretionary stock pickers. Manages over Rs 1.2 lakh crore. Founded by Sanjeev Sharma, Quant MF uses VLRT (Valuation, Liquidity, Risk, and Time) framework to run high-turnover, tactically active portfolios. Grew from obscurity to one of India's top-15 AMCs in under five years, attracting both retail capital and scrutiny for its aggressive churn.